1-4 of 4
C Sebban
Close
Sort by
Journal Articles

The International Prognostic Index Correlates to Survival in Patients With Aggressive Lymphoma in Relapse: Analysis of the PARMA Trial

J.-Y. Blay, F. Gomez, C. Sebban, T. Bachelot, P. Biron, C. Guglielmi, A. Hagenbeek, R. Somers, F. Chauvin, T. Philip
Journal: Blood
Blood (1998) 92 (10): 3562–3568.
https://doi.org/10.1182/blood.V92.10.3562
Published: 1998
Journal Articles

A Risk Model for Thrombocytopenia Requiring Platelet Transfusion After Cytotoxic Chemotherapy

J.Y. Blay, A. Le Cesne, C. Mermet, C. Maugard, A. Ravaud, C. Chevreau, C. Sebban, J.-P. Guastalla, P. Biron, I. Ray-Coquard
Journal: Blood
Blood (1998) 92 (2): 405–410.
https://doi.org/10.1182/blood.V92.2.405
Published: 1998
Journal Articles

Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia

C Boucheix, B David, C Sebban, E Racadot, MC Bene, A Bernard, L Campos, H Jouault, F Sigaux, E Lepage
Journal: Blood
Blood (1994) 84 (5): 1603–1612.
https://doi.org/10.1182/blood.V84.5.1603.1603
Published: 1994
Journal Articles

Intensive chemotherapy in aggressive lymphomas: updated results of LNH- 80 protocol and prognostic factors affecting response and survival

B Coiffier, PA Bryon, M Ffrench, M Blanc, C Sebban, F Berger, JJ Viala
Journal: Blood
Blood (1987) 70 (5): 1394–1399.
https://doi.org/10.1182/blood.V70.5.1394.1394
Published: 1987